SCHEMBL7873465

SCHEMBL7873465

CNC(N)=NC(=O)c1cc2cccc(Oc3cccc(CN(C)C)c3)c2[nH]1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.36
F10 P00742 1/20 0.36
IDO1 P14902 1/20 0.36
NOS1 P29475 1/20 0.36
ACHE P22303 6/20 0.36
BCHE P06276 3/20 0.35
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
HRH4 Q9H3N8 1/20 0.34
PARP1 P09874 1/20 0.34
PTGES O14684 1/20 0.33
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33
CHUK O15111 1/20 0.33
INSR P06213 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7880204 0.92 LSS (0.36) IDO1NOS1THRBHRH4PARP1
SCHEMBL7882052 0.90 PLAU (0.38) F10IDO1NOS1PPARGPPARD
SCHEMBL7879711 0.89 IDO1 (0.40) IDO1ACHELMNATP53MAPT
SCHEMBL7880990 0.87 MGMT (0.38) IDO1NOS1HRH4PARP1CHUK
SCHEMBL7873733 0.86 SLC6A4 (0.39) F2F10NOS1ACHEBCHE
SCHEMBL7877758 0.86 CHUK (0.36) IDO1NOS1LMNATP53MAPT
SCHEMBL7879703 0.86 TP53 (0.34) IDO1LMNATP53MAPTTHRB
SCHEMBL7878084 0.85 BRD4 (0.39) HRH4MTNR1AMTNR1BALDH1A1
SCHEMBL7877633 0.85 SLC6A2 (0.36) F2F10NOS1ACHEBCHE
SCHEMBL7878089 0.85 SLC6A4 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed